Closing 0.75

Buy sell Que manipulation

Hehe he

QR out at noon , profit

Bintai Kinden's two biggest shareholders dispose of shares in the group

0.20

Rail problem with HSR project
The line will now end in Johor instead of Singapore

What brand vaccine will Yong tai distribute, don't know yet

Otw

Penny stock keep issuing news shares, how la

Govt to seal vaccine purchase with Astrazeneca on Monday

By Bernama | 2020-12-19 17:38:17
KLUANG (Dec 19): The government will be concluding an agreement with AstraZeneca of United Kingdom on Monday to purchase Covid-19 vaccines to meet the immunisation needs of 20% of the people in the country.

Health Minister Datuk Seri Dr Adham Baba said this is the third agreement after the government signed with COVAX to buy 10% of its vaccine needs and with Pfizer to cover 20% of Malaysia’s requirement last month.

"On the overall, we will be purchasing vaccines for 50% of the people. We will try to get all vaccine supplies in the first quarter next year,” he told reporters after a symbolic handing over of Aerosol Intubation Box contribution by Universiti Teknologi Malaysia (UTM) to the Ministry of Health (MOH) in Simpang Renggam near here today.

Also present was UTM deputy vice chancellor (Research and Innovation) Prof Datuk Dr Ahmad Fauzi Ismail.

Dr Adham said at the same time, the government has to increase procurement of vaccines by another 20% to meet the needs of 70% of the people.

He said the government would look into attracting vaccine suppliers to meet the needs of the country.

“What is important is that companies which gave quick access to their vaccines must ensure they are safe, and of quality. Must also receive approval from the producing country as well as approval from MOH’s National Pharmaceutical Regulatory Agency (NPRA).

“If it is concluded, we can vaccinate the first Malaysians comprising frontliners in early 2021,” he said.

The media today reported that the first batch of vaccines will be arriving in February 2021 with supplies continuing until the end of 2021.

On Nov 24, Malaysia announced that it would be acquiring its initial supply for 12.8 million doses of Covid-19 vaccines from Pfizer to meet 20% of its immunisation needs or 6.4 million people for free.

Govt to seal vaccine purchase with Astrazeneca on Monday

By Bernama | 2020-12-19 17:38:17
KLUANG (Dec 19): The government will be concluding an agreement with AstraZeneca of United Kingdom on Monday to purchase Covid-19 vaccines to meet the immunisation needs of 20% of the people in the country.

Health Minister Datuk Seri Dr Adham Baba said this is the third agreement after the government signed with COVAX to buy 10% of its vaccine needs and with Pfizer to cover 20% of Malaysia’s requirement last month.

"On the overall, we will be purchasing vaccines for 50% of the people. We will try to get all vaccine supplies in the first quarter next year,” he told reporters after a symbolic handing over of Aerosol Intubation Box contribution by Universiti Teknologi Malaysia (UTM) to the Ministry of Health (MOH) in Simpang Renggam near here today.

Also present was UTM deputy vice chancellor (Research and Innovation) Prof Datuk Dr Ahmad Fauzi Ismail.

Dr Adham said at the same time, the government has to increase procurement of vaccines by another 20% to meet the needs of 70% of the people.

He said the government would look into attracting vaccine suppliers to meet the needs of the country.

“What is important is that companies which gave quick access to their vaccines must ensure they are safe, and of quality. Must also receive approval from the producing country as well as approval from MOH’s National Pharmaceutical Regulatory Agency (NPRA).

“If it is concluded, we can vaccinate the first Malaysians comprising frontliners in early 2021,” he said.

The media today reported that the first batch of vaccines will be arriving in February 2021 with supplies continuing until the end of 2021.

On Nov 24, Malaysia announced that it would be acquiring its initial supply for 12.8 million doses of Covid-19 vaccines from Pfizer to meet 20% of its immunisation needs or 6.4 million people for free.

are safe, and of quality. Must also receive approval from the producing country as well as approval from MOH’s National Pharmaceutical Regulatory Agency (NPRA).

“If it is concluded, we can vaccinate the first Malaysians comprising frontliners in early 2021,” he said.

The media today reported that the first batch of vaccines will be arriving in February 2021 with supplies continuing until the end of 2021.

On Nov 24, Malaysia announced that it would be acquiring its initial supply for 12.8 million doses of Covid-19 vaccines from Pfizer to meet 20% of its immunisation needs or 6.4 million people for free.

As stated in all news, it's for immunisation/prevention. Whichever Covid vaccine also the same.

Sleeping counter

0.80 then only can run to paradise

At the moment, the price does not justify. No fundamental yet means for goreng only.

HSR should stop in Singapore not johor, or else it will cause inconvenience.

QR today

Profit taking, lower closing

Fake buy volume in and out

Ah chai is having lobster dinner sponsored by anzo

@jk22 social media news are for public consumption, not to suit individual taste

Not enough vaccine in China?

China Secures 100 Million Doses of BioNTech Vaccine
Bloomberg News
December 15, 2020, 10:16 PM EST
Updated on December 16, 2020, 1:56 AM EST
BioNTech to supply vaccines to Fosun as part of marketing pact
Imported vaccines needed despite massive domestic production
The Pfizer-BioNTech Covid-19 vaccine.
The Pfizer-BioNTech Covid-19 vaccine. Photographer: Bing Guan/Bloomberg
A Chinese drugmaker has secured 100 million doses of the coronavirus vaccine co-developed by Pfizer Inc. and BioNTech SE, as the country seeks overseas shots in addition to home-made ones to ensure immunization for the world’s most populous nation.

Shanghai Fosun Pharmaceutical Group Co., which in March made an agreement with BioNTech to develop and market the mRNA shot in China, will make an advance payment of 250 million euros ($300 million) for an initial 50 million doses. The German vaccine maker will supply no fewer than 100 million doses for China by the end of 2021, Fosun said in a statement filed with the Hong Kong Stock Exchange Wednesday

China not enough vaccine ka

China Secures 100 Million Doses of BioNTech Vaccine
Bloomberg News
December 15, 2020, 10:16 PM EST
Updated on December 16, 2020, 1:56 AM EST
BioNTech to supply vaccines to Fosun as part of marketing pact
Imported vaccines needed despite massive domestic production
The Pfizer-BioNTech Covid-19 vaccine.
The Pfizer-BioNTech Covid-19 vaccine. Photographer: Bing Guan/Bloomberg
A Chinese drugmaker has secured 100 million doses of the coronavirus vaccine co-developed by Pfizer Inc. and BioNTech SE, as the country seeks overseas shots in addition to home-made ones to ensure immunization for the world’s most populous nation.

Shanghai Fosun Pharmaceutical Group Co., which in March made an agreement with BioNTech to develop and market the mRNA shot in China, will make an advance payment of 250 million euros ($300 million) for an initial 50 million doses. The German vaccine maker will supply no fewer than 100 million doses for China by the end of 2021, Fosun said in a statement filed with the Hong Kong Stock Exchange Wednesday

QR should be out first week December, overdue

Scrap HSR if line ends in JB

Wednesday, December 16th, 2020 at , Economy | News

Experts say without connection to Singapore, the project would cannibalise the market from other modes of transportation

by NUR HANANI AZMAN / pic by TMR FILE

IT IS better for the government to scrap the Kuala Lumpur-Singapore high-speed rail (HSR) project if the train service terminates in Johor Baru (JB), according to experts.

A transportation consultant YS Chan said Malaysia should cancel the agreement and compensate Singapore because without connection to the island, the project is not viable and would cannibalise the market from other modes of transportation on the same route.

“KTM Komuter has already embarked on double-tracking and services would be faster and more efficient. Express buses and airlines could do with more passengers, without HSR,” Chan told The Malaysian Reserve.

Wednesday, December 16th, 2020 at , Economy | News

Experts say without connection to Singapore, the project would cannibalise the market from other modes of transportation

by NUR HANANI AZMAN / pic by TMR FILE

IT IS better for the government to scrap the Kuala Lumpur-Singapore high-speed rail (HSR) project if the train service terminates in Johor Baru (JB), according to experts.

A transportation consultant YS Chan said Malaysia should cancel the agreement and compensate Singapore because without connection to the island, the project is not viable and would cannibalise the market from other modes of transportation on the same route.

“KTM Komuter has already embarked on double-tracking and services would be faster and more efficient. Express buses and airlines could do with more passengers, without HSR,” Chan told The Malaysian Reserve.

Bringing in foreign expert and workers is a problem due to Covid. Maybe after Covid is more settled down

Either HSR , ON, postpone, OFF. Unpredictable because of covid

Good chance for uptrend

No volume no goreng

Looking at the volume, mostly down trend

This HSR project, on then off then on off, no money and Covid is still around cannot start work.

It's not going to fly unless date of commencement of HSR project is announced.

Can only pray

Suspension so many think is great news, kena la

Uptrend time!

Today good day for icon

Usually any news also no up,, today up because US reasons

Bullish no doubt about it.

Besok ada chance naik

Lift off could be tomorrow

Esok mari

Needs really great news to wake up, like vaccine success to contain Covid

Bonus is 0.002

Moderna vaccine approval on Friday, buy keep.

Will rebound but not much

Tomorrow will be a game changer for velesto